Renin–angiotensin system (RAS) inhibitors — including angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) — slow the progression of mild or moderate chronic kidney ...
November 16, 2009 (Orlando, Florida) — An analysis of the Heart Outcomes Prevention Evaluation (HOPE) study has potentially identified a new biomarker of renin angiotensin system (RAS) activation that ...
ACE inhibitors work by interfering with the body's renin-angiotensin-aldosterone system (RAAS). RAAS is a complex system responsible for regulating the body's blood pressure. The kidneys release an ...
Given the common use of ACE inhibitors and ARBs worldwide, guidance on the use of these drugs in patients with Covid-19 is urgently needed. Here, we highlight that the data in humans are too limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results